World Workshop on Oral Medicine VII: Targeting the oral microbiome Part 2: Current knowledge on malignant and potentially malignant oral disorders.

head and neck cancer oral microbiome oral squamous cell carcinoma potentially malignant disorders of the oral mucosa

Journal

Oral diseases
ISSN: 1601-0825
Titre abrégé: Oral Dis
Pays: Denmark
ID NLM: 9508565

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 14 12 2018
revised: 19 03 2019
accepted: 11 04 2019
entrez: 30 5 2019
pubmed: 30 5 2019
medline: 3 1 2020
Statut: ppublish

Résumé

The World Workshop on Oral Medicine VII chose the oral microbiome as a focus area. Part 1 presents the methodological state of the science for oral microbiome studies. Part 2 was guided by the question: What is currently known about the microbiome associated with oral squamous cell carcinoma and potentially malignant disorders of the oral mucosa? A scoping review methodology was followed to identify and analyse relevant studies on the composition and potential functions of the oral microbiota using high-throughput sequencing techniques. The authors performed searches in PubMed and EMBASE. After removal of duplicates, a total of 239 potentially studies were identified. Twenty-three studies on oral squamous cell carcinoma, two on oral leukoplakia and four on oral lichen planus were included with substantial differences in diagnostic criteria, sample type, region sequenced and sequencing method utilised. The majority of studies focused on bacterial identification and recorded statistically significant differences in the oral microbiota associated with health and disease. However, even when comparing studies of similar methodology, the microbial differences between health and disease varied considerably. No consensus on the composition of the microbiomes associated with these conditions on genus and species level could be obtained. Six studies on oral squamous cell carcinoma had included in silico predicted microbial functions (genes and/or pathways) and found some similarities between the studies. Attempts to reveal the microbiome associated with oral mucosal diseases are still in its infancy, and the studies demonstrate significant clinical and methodological heterogeneity across disease categories. The immense richness and diversity of the microbiota clearly illustrate that there is a need for additional methodologically comparable studies utilising deep sequencing approaches in significant cohorts of subjects together with functional analyses. Our hope is that following the recipe as outlined in our preceding companion paper, that is Part 1, will enhance achieving this in the future and elucidate the role of the oral microbiome in oral squamous cell carcinoma and potentially malignant disorders of the oral mucosa.

Identifiants

pubmed: 31140694
doi: 10.1111/odi.13107
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

28-48

Subventions

Organisme : World Workshop on Oral Medicine (WWOM) VII

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. All rights reserved.

Auteurs

Jairo Robledo-Sierra (J)

Faculty of Dentistry, CES University, Medellin, Colombia.

Dalit Porat Ben-Amy (DP)

Oral Medicine Unit, Department of Oral & Maxillofacial Surgery, The Baruch Padeh Medical Center, Poriya, Israel.

Elena Varoni (E)

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.

Roxanne Bavarian (R)

Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, Massachusetts.
Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Harvard University, Cambridge, Massachusetts.

Janne L Simonsen (JL)

Aarhus University Library - Health Sciences, Aarhus University, Aarhus, Denmark.

Bruce J Paster (BJ)

The Forsyth Institute, Cambridge, Massachusetts.

William G Wade (WG)

Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, UK.

Ross Kerr (R)

Department of Oral and Maxillofacial Pathology, Radiology and Medicine, New York University College of Medicine, New York City, New York.

Douglas E Peterson (DE)

Oral Medicine Section, School of Dental Medicine, UConn Health, University of Connecticut, Mansfield, Connecticut.

Ellen Frandsen Lau (E)

Section for Periodontology, Department of Dentistry and Oral Health, Faculty of Health, Aarhus University, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH